Thursday, October 8, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleNasdaq· February 17, 2026

Stocks Retreat on AI Anxiety

View original at nasdaq.com
Stocks Retreat on AI Anxiety The S&P 500 Index ($SPX) (SPY) today is down -0.27%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.22%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.51%…
Opening lines of the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Full-year organic net sales forecast to be down 1.5% to 2.0%, reduced from previous forecast of -1% to +1%

    80% confidence
  • Elliott Investment Management has built a more than 10% stake in Norwegian Cruise Line

    80% confidence
  • Southwest Airlines upgraded to buy from neutral with $73 price target

    80% confidence
  • S&P earnings growth expected to climb by 8.4% in Q4, marking the tenth consecutive quarter of year-over-year growth

    80% confidence
  • Excluding the Magnificent Seven megacap technology stocks, Q4 earnings expected to increase by 4.6%

    80% confidence
  • AeroVironment rated overweight with $320 price target

    80% confidence
  • Activist investor Jana Partners has built a stake in Fiserv and is pushing for changes to improve stock performance

    80% confidence
  • Services inflation remains elevated, but there is potential for more interest rate cuts this year if inflation continues to return to the Fed's 2% target

    80% confidence
  • Danaher is closing in on a nearly $10 billion deal to acquire Masimo

    80% confidence
  • Full-year adjusted Ebitda forecast at $2.4 billion to $2.6 billion

    80% confidence
  • Warner Bros Discovery is considering reopening sale talks with Paramount Skydance

    80% confidence
  • 2026 adjusted EPS forecast at $8.70 to $9.90

    80% confidence
  • Full-year adjusted EPS forecast at $5.62 to $5.66

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com